Stipple Bio
Private Company
Funding information not available
Overview
Stipple Bio is a San Diego-based biotech founded in 2021, focused on developing a proprietary platform for high-resolution cellular profiling and target discovery. The company's mission centers on unlocking biological insights at the epitope level to drive the identification of novel therapeutic targets and biomarkers. While still in its early stages, Stipple Bio represents an emerging player in the rapidly evolving field of single-cell and spatial biology technologies.
Technology Platform
Proprietary platform for cellular profiling and target discovery with epitope resolution, enabling high-resolution analysis of protein targets and cellular states.
Opportunities
Risk Factors
Competitive Landscape
Competes with established spatial biology and single-cell analysis companies like 10x Genomics and NanoString, as well as emerging proteomics startups. Differentiation centers on epitope resolution capabilities and therapeutic discovery applications.